- Home
- NUVB vs BKE Comparison
NUVB vs BKE Comparison
Compare NUVB & BKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NUVB | BKE |
|---|---|---|
| Founded | 2018 | 1948 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.5B |
| IPO Year | N/A | 1992 |
Fundamental Metrics
Financial Performance| Metric | NUVB | BKE |
|---|---|---|
| Price | $5.72 | $52.06 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 1 |
| Target Price | $10.89 | ★ $55.00 |
| AVG Volume (30 Days) | ★ 6.6M | 570.9K |
| Earning Date | 03-05-2026 | 03-13-2026 |
| Dividend Yield | N/A | ★ 8.45% |
| EPS Growth | N/A | ★ 3.79 |
| EPS | N/A | ★ 4.09 |
| Revenue | $26,748,000.00 | ★ $1,277,894,000.00 |
| Revenue This Year | $636.92 | $7.42 |
| Revenue Next Year | $191.15 | $2.75 |
| P/E Ratio | ★ N/A | $12.75 |
| Revenue Growth | ★ 1137.19 | 4.67 |
| 52 Week Low | $1.54 | $33.12 |
| 52 Week High | $9.75 | $61.69 |
Technical Indicators
Market Signals| Indicator | NUVB | BKE |
|---|---|---|
| Relative Strength Index (RSI) | 43.91 | 50.03 |
| Support Level | $5.51 | $46.59 |
| Resistance Level | $6.22 | $49.49 |
| Average True Range (ATR) | 0.36 | 1.71 |
| MACD | 0.07 | 0.19 |
| Stochastic Oscillator | 79.65 | 55.91 |
Price Performance
Historical ComparisonAbout NUVB Nuvation Bio Inc.
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.
About BKE Buckle Inc. (The)
Buckle Inc is a retailer of casual apparel, footwear, and accessories. The company retails medium to affordable priced casual apparel, footwear, and accessories for fashion-conscious young men and women. It retails under the brand names 'Buckle' and 'The Buckle'. Buckle markets a wide selection of mostly brand-name casual apparel including denim, other casual bottoms, tops, sportswear, outerwear, accessories, and footwear.